Sanofi | Income Statement
Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
32,951
31,694
34,060
33,821
35,055
34,463
Cost of Goods Sold (COGS) incl. D&A
14,049
12,445
13,169
12,504
13,594
13,723
Gross Income
18,902
19,249
20,891
21,317
21,461
20,740
SG&A Expense
13,302
13,034
14,399
14,586
15,455
15,662
EBIT
-
-
-
6,731
6,015
5,081
Unusual Expense
1,125
607
1,474
1,607
1,208
2,227
Non Operating Income/Expense
535
389
584
877
1,013
1,950
Interest Expense
457
441
416
379
346
471
Pretax Income
4,602
5,658
5,243
5,678
5,530
4,405
Income Tax
763
1,214
709
1,326
1,722
481
Equity in Affiliates
35
52
22
134
104
499
Consolidated Net Income
3,874
4,392
4,512
4,486
3,912
4,423
Net Income
3,716
4,273
4,411
4,395
3,791
4,319
Net Income After Extraordinaries
3,716
4,156
4,535
4,081
852
4,332
Net Income Available to Common
3,716
4,390
4,287
4,709
3,791
4,319
EPS (Basic)
2.81
3.34
3.28
3.66
6.71
3.45
Basic Shares Outstanding
1,323
1,316
1,306
1,287
1,257
1,247
EPS (Diluted)
2.77
3.30
3.25
3.63
6.66
3.43
Diluted Shares Outstanding
1,339
1,331
1,321
1,296
1,267
1,255
EBITDA
9,823
9,988
10,486
9,721
9,167
8,545
Other Operating Expense
-
-
-
-
9
3
Non-Operating Interest Income
49
102
57
56
56
72
Minority Interest Expense
158
119
101
91
121
104
About Sanofi
View Profile
